Zealand Pharma A/s Stock
€109.60
Your prediction
Financial data and news for Zealand
sharewise wants to provide you with the best news and tools for Zealand, so we directly link to the best financial data sources.
Financials
News
Better Buy: Celsius Stock at a 52-Week Low or a 50/50 Split of Dividend Kings Pepsi and Coca-Cola?
The beverage industry doesn't get disrupted easily. Sure, new products may catch on as fads. But it's rare for a brand to achieve global recognition.
Red Bull pioneered the energy drink industry and
Prediction: This Hypergrowth Space Stock Will Be Worth More Than SpaceX In 10 Years
SpaceX has been a remarkable success over the last 15 years. It brought the space flight industry in the United States -- really, around the world -- back to life and inspired plenty of copycats
This Rising Biotech Is a Fantastic Weight-Loss Stock to Buy Now
As we all know, the weight-loss drug revolution is making a lot of companies rich, and the party's just getting started. Weight-loss drug developers like the Danish biotech Zealand Pharma (OTC:
Prediction: Rocket Lab Gets a New Neighbor in SpaceX
Five years ago -- even before its IPO -- small rocket company and SpaceX rival Rocket Lab USA (NASDAQ: RKLB) had an announcement to make.
Despite its name, Rocket Lab was primarily a New Zealand
Why Latham Group Stock Is Making a Splash Today
Swimming pool manufacturer Latham Group (NASDAQ: SWIM) rode a wave of cost cuts to better-than-expected earnings. Investors are diving in, sending Latham shares up 42% as of 2:30 p.m. ET.
Latham
Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio
Eli Lilly (NYSE: LLY) has become a big name in the anti-obesity market with the recent approval of Zepbound, which is likely to rake in billions in revenue alongside Mounjaro, the company's diabetes